Second, we analyzed long-term, PCa-specific outcomes among patients based on a single PSA value taken between the ages of 55 and 60 years, but we did not analyze other PSA metrics, such as PSA density or velocity. The gene discussed is KLK3; the disease is posterior cortical atrophy.